在功能性消化不良和便秘占主导地位的刺激性肠综合征重叠中的利卡洛的有效性:一项随机试验
Li Cheng1, Qianqian Wang1, Biyu Wu1
1Key Laboratory of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, Division of Gastroenterology and Hepatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Journal of gastroenterology and hepatology
|March 13, 2025
概括
利纳克洛有效地治疗重叠的功能性消化不良和便秘占主导地位的刺激性肠综合征症状,表现优于乳糖. 这项研究强调了利纳克洛提德作为患有这些综合性胃肠道疾病的患者的优越选择.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 临床试验研究 临床试验研究
背景情况:
- 便秘占主导地位的刺激性肠综合征 (IBS-C) 显著影响生活质量.
- 功能性消化不良 (FD) 经常与IBS-C同时发生,使治疗复杂化.
- 利纳克洛提德已被批准用于IBS-C,但其在重叠的FD-IBS-C中的有效性需要进一步研究.
研究的目的:
- 在患有重叠FD和IBS-C的患者中,比较林纳克洛提德与乳糖的疗效.
- 评估治疗满意度和特定胃肠道和心理症状的变化.
主要方法:
- 一项随机对照试验涉及78名患有FD和IBS-C重叠的患者.
- 参与者接受了利纳克洛提德 (每天290微克) 或乳糖 (每天20毫升) 治疗4周.
- 主要终点:整体治疗满意度;次要终点:FD,IBS-C和心理症状得分的变化.
主要成果:
- 与乳糖 (54.2%) (p=0.002) 相比,服用利纳克洛的患者中显著增加的比例报告了症状缓解 (87.2%).
- 利纳克洛提德在消化不良 (例如,胀气,早) 和肠道症状 (例如,便频率,疲劳) (p<0.05) 中都表现出优异的改善.
结论:
- 在管理重叠的功能性消化不良和便秘占主导地位的刺激性肠综合征方面,林卡洛比乳糖更有效.
- 利纳克洛提德为经历上下胃肠道综合症状的患者提供了一个有前途的治疗选择.
相关概念视频
01:21Drugs for Treatment of Constipation-Predominant IBS
124
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
124
01:17Drugs for Treatment of Diarrhea-Predominant IBS
133
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
133
01:20Drugs Affecting GI Tract Motility: Other Laxatives
143
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
143
01:22Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
160
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
160
01:17Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
153
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
153
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
201
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
201